![Evolent Health's SWOT analysis: stock faces challenges amid growth potential](https://i-invdn-com.investing.com/news/World_News_9_150x108_S_1420026261.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 100.000 | 100.000 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.908 | 15.123 |
Price to Book | 1.942 | 2.130 |
Price to Sales | 1.405 | 1.542 |
Price to Cash Flow | 8.551 | 9.095 |
Dividend Yield | 3.304 | 2.713 |
5 Years Earnings Growth | 8.973 | 9.803 |
Number of long holdings: 1
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Obligacionesei 0,65% Nv27 Eur | ES00000128S2 | 0.00 | 100.38 | 0.00% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Plancaixa Proyeccion 2029 PP | 22.51M | 0.03 | -2.99 | 0.73 | ||
Plancaixa Futuro 160 | 3.26M | 0.10 | -1.23 | 0.88 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review